BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25306774)

  • 1. Evaluation of the stability of fluoxetine in pluronic lecithin organogel and the determination of an appropriate beyond-use date.
    Peacock GF; Sauvageot J
    Int J Pharm Compd; 2014; 18(3):253-5. PubMed ID: 25306774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the stability of ketoprofen in pluronic lecithin organogel and the determination of an appropriate beyond-use date.
    Peacock GF; Sauvageot J; Addo RT
    Int J Pharm Compd; 2014; 18(4):348-50. PubMed ID: 25474865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the stability of promethazine hydrochloride in pluronic lecithin organogel and the determination of an appropriate beyond-use date.
    Peacock GF; Sauvageot J
    Int J Pharm Compd; 2014; 18(4):345-7. PubMed ID: 25474864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and in vitro evaluation of a pluronic lecithin organogel containing ricinoleic acid for transdermal delivery.
    Boddu SH; Bonam SP; Wei Y; Alexander K
    Int J Pharm Compd; 2014; 18(3):256-61. PubMed ID: 25306775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the stability of acetaminophen in pluronic lecithin organogel and the determination of an appropriate beyond-use date.
    Peacock GF; Sauvageot J
    Int J Pharm Compd; 2012; 16(5):428-30. PubMed ID: 23072202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and evaluation of novel controlled release of topical pluronic lecithin organogel of mefenamic acid.
    Jhawat V; Gupta S; Saini V
    Drug Deliv; 2016 Nov; 23(9):3573-3581. PubMed ID: 27494650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical Stability and Release Profile of Compounded Gabapentin Containing Pluronic Lecithin Organogel for Neuropathic Pain Management.
    Hong EJ; Sumanasekera W; Le UM
    Int J Pharm Compd; 2022; 26(1):65-71. PubMed ID: 35081046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation of tubular micelles of pluronic lecithin organogel for transdermal delivery of sumatriptan.
    Agrawal V; Gupta V; Ramteke S; Trivedi P
    AAPS PharmSciTech; 2010 Dec; 11(4):1718-25. PubMed ID: 21128126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pluronic lecithin organogel as a topical drug delivery system.
    Pandey M; Belgamwar V; Gattani S; Surana S; Tekade A
    Drug Deliv; 2010 Jan; 17(1):38-47. PubMed ID: 22747074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propolis organogel as a novel topical delivery system for treating wounds.
    Balata G; El Nahas HM; Radwan S
    Drug Deliv; 2014 Feb; 21(1):55-61. PubMed ID: 24295500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and characterization of a ricinoleic acid poloxamer gel system for transdermal eyelid delivery.
    Boddu SH; Bonam SP; Jung R
    Drug Dev Ind Pharm; 2015 Apr; 41(4):605-12. PubMed ID: 24517574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and clinical evaluation of silymarin pluronic-lecithin organogels for treatment of atopic dermatitis.
    Mady FM; Essa H; El-Ammawi T; Abdelkader H; Hussein AK
    Drug Des Devel Ther; 2016; 10():1101-10. PubMed ID: 27022248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of Pluronic lecithin organogels in the transdermal delivery of drugs.
    Bramwell BL; Williams LA
    Int J Pharm Compd; 2012; 16(1):62-3. PubMed ID: 23050314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gabapentin in Elastic Liposomes: Preparation, Characterization, Drug Release, and Penetration Through Porcine Skin.
    Le UM; Baltzley S; AlGhananeem A
    Int J Pharm Compd; 2018; 22(6):498-503. PubMed ID: 30384350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, Development and
    Chauhan S; Jhawat V; Singh RP; Yadav A; Garg V
    Recent Adv Drug Deliv Formul; 2024; 18(1):50-60. PubMed ID: 38284692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of formulation pH on transdermal penetration of antiemetics formulated in poloxamer lecithin organogel.
    Woodall R; Arnold JJ; McKay D; Asbill CS
    Int J Pharm Compd; 2013; 17(3):247-53. PubMed ID: 24046940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pluronic lecithin organogel (PLO) of diltiazem hydrochloride: effect of solvents/penetration enhancers on ex vivo permeation.
    Parhi R; Suresh P; Pattnaik S
    Drug Deliv Transl Res; 2016 Jun; 6(3):243-53. PubMed ID: 26754742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of gelation process and drug release profile of thermosensitive liquid lecithin/poloxamer 407 based gels as carriers for percutaneous delivery of ibuprofen.
    Djekic L; Krajisnik D; Martinovic M; Djordjevic D; Primorac M
    Int J Pharm; 2015 Jul; 490(1-2):180-9. PubMed ID: 26002567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of pluronic lecithin organogel containing fluocinolone acetonide.
    Patel D; Patel V
    Drug Dev Ind Pharm; 2021 Mar; 47(3):377-384. PubMed ID: 33493079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, characterization, and in vitro release of new transdermal methimazole as alternative to oral delivery.
    Morales ME; Clarés B; López-Viota M; Ruiz MA
    Drug Deliv; 2009 Jan; 16(1):1-10. PubMed ID: 19555302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.